DARE - Wutah dodolan YoY (TTM) Dare Bioscience, Inc.

Logo perusahaan publik Daré Bioscience, Inc. (DARE)

The success of Dare Bioscience, Inc. (DARE) is based on the commercialization of XACIATO and progress in the development of contraceptives. The company's environmental responsibility is reflected in its compliance with WHO standards for reagent disposal. The last twelve months (LTM) revenue growth rate clearly confirms these processes, where the value of 0.00 serves as the current metric. Business stability is bolstered by a strong staff of specialized scientists and reproductive health experts.

DARE - Wutah dodolan YoY (TTM) Dare Bioscience, Inc. ing rentang 11.02.2024 - 16.11.2026

Daré Bioscience (DARE) - rincian metrik lan laporan keuangan

- rega saham lan prakiraan rega para ahli:
Ringkesan analitik perusahaan:DARE Daré Bioscience, Inc.
Produk merek darebioscience.com

This indicator assesses business expansion rates by comparing total revenue from the last four quarters against the same prior period. The metric identifies cash flow stability and real market demand for the product. The year-over-year sales growth trajectory over the TTM reflects the commercialization efficiency of women's health products from Dare Bioscience, Inc. (DARE). Analyzing this trend allows for the determination of the company's transition stage from research and development to profit scaling. A positive trend confirms the asset's investment attractiveness.